Sources | Names Used |
---|---|
CTRPv2 | BRD-K02251932 |
PharmacoGx | BRD-K02251932 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RASGRP2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.07 |
mRNA | LILRA2 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
mRNA | RNF169 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
mRNA | ANKZF1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
mRNA | ATP13A1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
mRNA | CYFIP1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
mRNA | GLT1D1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
mRNA | ZFP2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
mRNA | PHF20L1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
mRNA | FAM209A | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |